Immune Predictors of Response after Bacillus <i>Calmette–Guérin</i> Treatment in Non-Muscle-Invasive Bladder Cancer

Immune Predictors of Response after Bacillus <i>Calmette–Guérin</i> Treatment in Non-Muscle-Invasive Bladder Cancer

Bacillus Calmette–Guérin (BCG) has been the standard of care for the treatment of high-risk, non-muscle-invasive bladder cancer (NMIBC) for decades, but 49.6% of high-risk and very-high-risk patients will experience progression to muscle-invasive disease in five years. Furthermore, cytology and cyst...

Full description

Bibliographic Details
Main Authors:	Marta Rodríguez-Izquierdo, Carmen G. Del Cañizo, Carolina Rubio, Ignacio A. Reina, Mario Hernández Arroyo, Alfredo Rodríguez Antolín, Marta Dueñas Porto, Félix Guerrero-Ramos
Format:	Article
Language:	English
Published:	MDPI AG 2023-11-01
Series:	Cancers
Subjects:	bladder cancer Bacillus <i>Calmette–Guérin</i> cytokines tumor microenvironment immune response
Online Access:	https://www.mdpi.com/2072-6694/15/23/5554

Similar Items

Bacillus Calmette–Guérin and Bladder Cancer
by: Azad H.A. Razack
Published: (2007-10-01)

GSK2656157, a PERK Inhibitor, Alleviates Pyroptosis of Macrophages Induced by Mycobacterium <i>Bacillus Calmette–Guerin</i> Infection
by: Boli Ma, et al.
Published: (2023-11-01)

Reaction at the Bacillus Calmette–Guérin Inoculation Site in Patients with Kawasaki Disease
by: Chi-Chieh Lai, et al.
Published: (2013-02-01)

Granulomatous Hepatitis Following Intra-Vesical Instillation of Bacillus Calmette–Guérin for Treatment of Bladder Cancer
by: Elsa Alves Branco, et al.
Published: (2021-07-01)

Bacillus Calmette-Guerin Increases Base Excision Repair in Bladder Cancer Cells
by: Selçuk Keskin, et al.
Published: (2021-03-01)

Exploring the role of bacillus calmette–guerin vaccination in protection against COVID-19
by: Anil Chauhan, et al.
Published: (2021-01-01)

Breast abscess due to Bacillus Calmette-Guérin
by: Aurélien Dinh, et al.
Published: (2017-06-01)

Single course of intravesical Bacillus Calmette–Guerin versus single course with maintenance therapy in the management of nonmuscle invasive bladder cancer: A prospective randomized study
by: Mohamed Bakr Mohamed, et al.
Published: (2020-01-01)

The impact of Bacillus Calmette-Guérin (BCG) vaccination on the course of COVID-19
by: Jakub Krzysztof Gałązka
Published: (2022-10-01)

Adverse reactions due to the bacillus Calmette-Guerin vaccine: Twenty Tunisian cases
by: Khadija Sellami, et al.
Published: (2018-01-01)

Measles infection causing Bacillus Calmette-Guérin reactivation: a case report
by: Sobana Muthuvelu, et al.
Published: (2019-07-01)

DIAGNOSTIC VALUE OF THE REACTION AT THE BACILLUS CALMETTE-GUÉRIN VACCINATION SITE IN KAWASAKI DISEASE
by: Lilian Martins Oliveira Diniz, et al.
Published: (2020-08-01)

Regression of the Sweet's syndrome after Bacillus Calmette-Guérin therapy: A bladder cancer case report
by: İbrahim Halil Baloglu, et al.
Published: (2020-07-01)

Childhood lupus vulgaris after Bacillus Calmette–Guérin vaccine
by: Sarah Hamdy Soliman, et al.
Published: (2023-01-01)

Bacillus Calmette–Guerin immunotherapy for recurrent multiple warts: An open-label uncontrolled study
by: Avtar Kishan Jaisinghani, et al.
Published: (2019-01-01)

The immunopathology of tuberculosis, the mode of action of the Bacillus Calmette-Guérin, of the tuberculin and of the immunotherapy
by: Roland Maes
Published: (2019-01-01)

An Interesting Similarity of Bacillus Calmette-Guerin and Chimeric Antigen Receptor T Cells
by: Seyed Saeed Tamehri Zadeh, et al.
Published: (2020-08-01)

Dual Bacillus Calmette–Guerin vaccination along the border communities of Angola and Namibia
by: Abubakar Sadiq Umar, et al.
Published: (2016-01-01)

New-onset guttate psoriasis following intravesical immunotherapy of Bacillus Calmette–Guerin
by: Chih-Tsung Hung, et al.
Published: (2012-09-01)

Ten Years' Experience with the Discontinuation of the Bacillus Calmette–Guérin Vaccination in the Czech Republic
by: Karolína Dolezalová, et al.
Published: (2021-01-01)

Intralesional Avirulent Bacillus Calmette-Guérin Injection as a Promising Method for the Treatment of Tuberculosis Verrucosa Cutis
by: Özgür Gündüz, et al.
Published: (2022-03-01)

Intravesical bacillus Calmette-Guerin (BCG) in treating non-muscle invasive bladder cancer—analysis of adverse effects and effectiveness of two strains of BCG (Danish 1331 and Moscow-I)
by: Yuvaraja B. Thyavihally, et al.
Published: (2022-04-01)

Intravesical Bacillus Calmette-Guérin (BCG) treatment's severe complications: A single institution review of incidence, presentation and treatment outcome
by: R. Waked, et al.
Published: (2020-05-01)

Successful treatment of anogenital warts with single dose Bacillus Calmette Guerin vaccine without prior sensitization in tuberculosis endemic country: Two case report
by: Pati Aji Achdiat, et al.
Published: (2023-01-01)

Basal Cell Carcinoma Arising within a Bacillus Calmette-Guerin Scar: Case Report and Literature Review
by: Kinga Tyczyńska, et al.
Published: (2022-02-01)

Impact of intravesical Bacillus Calmette-Guérin and chemotherapy on the bladder microbiome in patients with non-muscle invasive bladder cancer
by: Christopher James, et al.
Published: (2023-04-01)

FGFBP1 as a potential biomarker predicting bacillus Calmette–Guérin response in bladder cancer
by: Fei Li, et al.
Published: (2022-09-01)

A randomized trial comparing low dose (40 or 80 mg) with standard dose (120 mg) of bacillus Calmette-Guerin for superficial bladder cancer
by: Vivek Vijjan, et al.
Published: (2006-01-01)

First vaccination after birth: serious adverse events of Bacillus Calmette-Guérin (BCG) in real-world
by: Jinmiao Lu, et al.
Published: (2022-11-01)

Two-stage posterior decompression and fusion for tuberculous spondylitis after intravesical bacillus Calmette-Guerin instillation
by: Hiroki Ohata, et al.
Published: (2021-01-01)

Penile lesion with inguinal adenopathy after intravesical Bacillus Calmette-Guerin instillation therapy
by: Guven Aslan, et al.
Published: (2013-01-01)

A case of Mycobacterium bovis Bacillus Calmette-Guérin (BCG) strain meningitis and ventriculitis following BCG vaccination
by: Mihoko Furuichi, et al.
Published: (2020-11-01)

A Case of Bacillus Calmette-Guérin Cystitis Diagnosed with a Novel Loop-mediated Isothermal Amplification Method
by: Kazuyoshi Tachi, et al.
Published: (2017-09-01)

Bacillus Calmette–Guerin intravesical instillation therapy-induced urothelial necrosis of the bladder and upper urinary tract
by: Tsubasa Kondo, et al.
Published: (2022-09-01)

Tuberculous epididymo-orchitis secondary to Bacillus Calmette-Guérin (BCG) in non-muscular invasive bladder cancer
by: Luis Felipe Lara Moscoloni, et al.
Published: (2021-07-01)

The role of Bacillus Calmette-Guérin administration on the risk of dementia in bladder cancer patients: a systematic review and meta-analysis
by: Chao Han, et al.
Published: (2023-08-01)

Lessons from Bacillus Calmette-Guérin: Harnessing Trained Immunity for Vaccine Development
by: Samuel T. Pasco, et al.
Published: (2020-09-01)

Partial Versus Complete Bacillus Calmette-Guérin Intravesical Therapy and Bladder Cancer Outcomes in High-risk Non–muscle-invasive Bladder Cancer: Is NIMBUS the Full Story?
by: Michael E. Rezaee, et al.
Published: (2021-04-01)

The natural course of bacillus Calmette-Guérin induced bladder lesions: A long-term follow-up study and systematic review
by: Chong Ma, et al.
Published: (2023-07-01)

Bacillus Calmette-Guérin (BCG)-Vaccine Is it giving a protection against SARS-CoV-2?
by: Mehnaz Tanveer, et al.
Published: (2022-06-01)